Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
2022.
Aspirin/nadroparin-calcium.
Reactions Weekly,
Vol. 1929,
Issue. 1,
p.
110.
2022.
Isoprenaline.
Reactions Weekly,
Vol. 1929,
Issue. 1,
p.
364.
2022.
Colchicine/nonsteroidal-anti-inflammatories/steroids.
Reactions Weekly,
Vol. 1929,
Issue. 1,
p.
196.
2022.
Cibenzoline.
Reactions Weekly,
Vol. 1932,
Issue. 1,
p.
181.
2022.
Alteplase.
Reactions Weekly,
Vol. 1929,
Issue. 1,
p.
30.
2022.
Covid-19-vaccine.
Reactions Weekly,
Vol. 1930,
Issue. 1,
p.
208.
2022.
COVID-19-vaccine-pfizer-biontech/lisinopril/metoprolol.
Reactions Weekly,
Vol. 1929,
Issue. 1,
p.
210.
2022.
Multiple drugs.
Reactions Weekly,
Vol. 1932,
Issue. 1,
p.
427.
2022.
Antineoplastics.
Reactions Weekly,
Vol. 1929,
Issue. 1,
p.
79.
2023.
Salbutamol.
Reactions Weekly,
Vol. 1938,
Issue. 1,
p.
1149.
2023.
Esmolol/lidocaine/magnesium.
Reactions Weekly,
Vol. 1943,
Issue. 1,
p.
314.
2023.
Levosimendan.
Reactions Weekly,
Vol. 1940,
Issue. 1,
p.
239.
Abell, Bridget R.
Eagleson, Karen
Auld, Benjamin
Bora, Samudragupta
Justo, Robert
Parsonage, William
Sharma, Pakhi
Kularatna, Sanjeewa
and
McPhail, Steven M.
2024.
Implementing neurodevelopmental follow‐up care for children with congenital heart disease: A scoping review with evidence mapping.
Developmental Medicine & Child Neurology,
Vol. 66,
Issue. 2,
p.
161.